Avita Medical (ASX:AVH) said today that it closed the $2.64 million deal for its respiratory business with Medical Developments International. The division includes Avita’s Breath-A-Tech and Funhaler asthma spacers designed to optimize the use of medicinal puffers, marketed in Australian pharmacies. The buyout was announced in December 2015. “With the sale of the respiratory business, we […]